Fertility-female polycystic ovary syndrome
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Non-pregnant, overweight and obese adult females with PCOS, aged 20 ¿ 40 years
Exclusion criteria
Exclusion criteria: The following subjects were excluded from the study: ¿ Subjects having type 1 or type 2 diabetes. ¿ Subjects receiving metformin within the last month. ¿ Subjects receiving ovulation induction medications within the last month. ¿ Subjects following a diet regimen within the last month.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the effects of lifestyle modification with or without metformin on anthropometric, metabolic, endocrine and inflammatory markers in overweight and obese women with polycystic ovary syndrome. | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess the effects of dietary recalibration, exercise and behavioural modification with or without metformin on regain of menstrual cyclicity and spontaneous pregnancy rates, and to compare the value of Acute-phase serum amyloid A as a surrogate marker for prognostic evaluation of the metabokic profile in overwight and obese women with PCOS in relation to C-reactive protein (CRP) | — |
Countries
Egypt
Contacts
Women's Health and Nutrition Clinic